Bicycle Therapeutics plc (BCYC) Misses Q2 EPS by 6c

Bicycle Therapeutics plc (NASDAQ: BCYC) reported Q2 EPS of ($0.90), $0.06 worse than the analyst estimate of ($0.84). Revenue for the quarter came in at $4.38 million versus the consensus estimate of $3.69 million.

For earnings history and earnings-related data on Bicycle Therapeutics plc (BCYC) click here.

You May Also Be Interested In

• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
• Herbalife reaffirms Q3 and full-year 2026 financial guidance
• Celanese to sell 19% Nutrinova stake to Mitsui for $152 million